198 related articles for article (PubMed ID: 11925608)
1. Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.
Nie QH; Cheng YQ; Xie YM; Zhou YX; Bai XG; Cao YZ
World J Gastroenterol; 2002 Apr; 8(2):282-7. PubMed ID: 11925608
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of tissue inhibitors of metallproteinases-1 and -2 in serum and liver tissue of patients with liver cirrhosis].
Nie Q; Zhou Y; Xie Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):805-7. PubMed ID: 11798971
[TBL] [Abstract][Full Text] [Related]
3. Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis.
Nie QH; Duan GR; Luo XD; Xie YM; Luo H; Zhou YX; Pan BR
World J Gastroenterol; 2004 Jan; 10(1):86-90. PubMed ID: 14695775
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.
Xu GF; Li PT; Wang XY; Jia X; Tian DL; Jiang LD; Yang JX
World J Gastroenterol; 2004 Dec; 10(24):3621-7. PubMed ID: 15534918
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
Boeker KH; Haberkorn CI; Michels D; Flemming P; Manns MP; Lichtinghagen R
Clin Chim Acta; 2002 Feb; 316(1-2):71-81. PubMed ID: 11750276
[TBL] [Abstract][Full Text] [Related]
9. The Role of Tissue Inhibitor of Metalloproteinase-1 and 2 in Echinococcus granulosus senso lato-Induced Human Hepatic Fibrosis.
Hasanzadeh A; Rafiei A; Kazemi M; Beiromvand M; Bahreini A; Khanahmad H
Acta Parasitol; 2022 Jun; 67(2):851-857. PubMed ID: 35294975
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
Arthur MJ; Mann DA; Iredale JP
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
[TBL] [Abstract][Full Text] [Related]
11. Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models.
Nie QH; Zhang YF; Xie YM; Luo XD; Shao B; Li J; Zhou YX
World J Gastroenterol; 2006 May; 12(19):3044-9. PubMed ID: 16718785
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.
Nie QH; Cheng YQ; Xie YM; Zhou YX; Cao YZ
World J Gastroenterol; 2001 Jun; 7(3):363-9. PubMed ID: 11819791
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Badra G; Lotfy M; El-Refaie A; Obada M; Abdelmonem E; Kandeel S; Fathy A
Acta Microbiol Immunol Hung; 2010 Mar; 57(1):29-42. PubMed ID: 20350877
[TBL] [Abstract][Full Text] [Related]
15. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
Arthur MJ
Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G245-9. PubMed ID: 10915630
[TBL] [Abstract][Full Text] [Related]
16. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells.
Zhang LJ; Chen YX; Chen ZX; Huang YH; Yu JP; Wang XZ
World J Gastroenterol; 2004 Sep; 10(17):2574-9. PubMed ID: 15300910
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
Sun W; Gui S; Wu L; Wang H; Wei W
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer.
Joo YE; Seo KS; Kim HS; Rew JS; Park CS; Kim SJ
Dig Dis Sci; 2000 Jan; 45(1):114-21. PubMed ID: 10695623
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10.
Zheng WD; Zhang LJ; Shi MN; Chen ZX; Chen YX; Huang YH; Wang XZ
World J Gastroenterol; 2005 Mar; 11(12):1753-8. PubMed ID: 15793858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
